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Anthropological studies of human biology are predominately field-based, and burdened, 
by the need for well-preserved biological samples. In the emerging application of multi-
omics, definitions of “well-preserved” and preservation strategies have had limited study, 
particularly those data that inform the biology of the human ecology. These human 
ecological data are a frequent objective of metabolomics and microbiome research. 
Metabolomics, through exploration of the totality of small molecules known as 
metabolites, offers a way to directly observe the molecular phenotype. These small 
molecules offer just as much valuable information to molecular anthropology as DNA 
and RNA, but there is a surprising lack of inquiry into how these molecules are preserved 
in samples and how molecular preservation impacts results and interpretations. For most 
metabolomic studies, the standard sample collection procedure involves snap-freezing the 
sample within 15 minutes of collection and storing at -80ºC. However, this is often 
unfeasible for field-based sample collection. Metabolome taphonomy, the study of how 
metabolome profiles are impacted by environmental processes as well as sample 
collection and preservation/preparation strategies, is still poorly understood. This thesis 
considers sample storage, with attention to human gut microbial samples. Consequently, 
this thesis presents two complementary studies, one with a focus on the metabolome and 
one focused on the microbiome taxonomic inventory, to determine if the application of 
the common DNA and RNA preservative RNAlater provides a valuable method for 
conserving ecological data from both approaches. Ten human fecal samples previously 




that simulates different levels of cold storage in the field: 22-25ºC, 4ºC, and -80ºC. To 
assess the impact of preservation methods on metabolite and bacterial taxonomic profiles, 
subsets of these aliquots were further treated with different preservation techniques, such 
as RNAlater. Metabolomic and bacterial taxonomic profiles were characterized using 
liquid chromatography-tandem mass spectrometry and 16S rRNA amplicon sequencing, 
respectively. These results will inform field sample collection and best storage practices 





  The molecular understanding of human biology has entered a golden era driven 
by technological and protocol innovations that have allowed for a deeper characterization 
of the genome, and the molecules driving the phenotype above the genome, identified by 
the fields of transcriptomics (RNA), proteomics (proteins), and metabolomics 
(metabolites). However, the quality of these “-omic” big data remains contingent on the 
biological samples themselves. Common to biological anthropology are samples 
collected from challenging field sites, whose remote conditions can impact sample 
preservation. Field-based studies of the human microbiome and metabolome are arguably 
more sensitive to sample preservation issues than human genome studies because they 
not only require proper DNA and molecular preservation, but also, unbiased frequency 
and abundance profiles of the organisms, genes, metabolic pathways, and/or particles the 
DNA and metabolites represent. 
 Despite these concerns, there is a surprising lack of inquiry into how small 
molecules are preserved in samples and how this preservation impacts results. This thesis 
project addresses preservation concerns with regards to time, storage temperature, and a 
storage solution called RNAlater. To address these preservation issues, a two-pronged 
approach was adopted, one that uses mass spectrometry-based metabolomics and a 
complementary approach that uses bacterial taxonomic 16S rRNA gene sequencing. 
Through these approaches, we explore how RNAlater and storage conditions affect our 
data generation, whether these sample treatment steps introduce taxonomic and 
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compositional biases, and how sample preservation techniques might be improved. By 
addressing such preservation issues, we hope to improve the current methods used to 
explore molecular anthropology. 
 
RNAlater and Sample Preservation 
 The common standard for ensuring sample integrity involves freezing a 
sampleimmediately after collection (Fiehn 2002; Gorokhova 2005; Reck et al. 2015; van 
Eijsden et al. 2013)⁠. This can include snap freezing, freezing with liquid nitrogen, or 
placing the samples in a freezer. However, this is not always feasible in certain 
environments. Remote field sites rarely have access to cold storage technologies, making 
sample preservation complicated. This issue is especially problematic for RNA-based 
projects due to the rapid degradation of RNA (Reck et al. 2015)⁠. Several sample storage 
solutions were developed to overcome these in-field sample preservation concerns. One 
such common reagent, called RNAlater, is the focus of inquiry for this project.  
 Ambion Invitrogen RNAlater Stabilization Storage Solution, referred to hereafter 
as RNAlater, is an aqueous storage reagent designed to preserve RNA in tissue samples 
(Lader 2001)⁠. Since its creation in the late 1990s, studies have demonstrated its efficacy 
at preserving not just RNA, but all nucleic acids (Gorokhova 2005; van Eijsden et al. 
2013)⁠. Furthermore, RNAlater has been proven practical at preserving nucleic acids 
within varying sample material. This includes bone (Cottrell et al. 2015)⁠, urine (Cheng et 
al. 2016)⁠, and feces (Reck et al. 2015)⁠. While in-house ingredients can vary, RNAlater is 
typically comprised of sodium citrate, ethylenediaminetetraacetic acid, ammonium 
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sulfate, and a buffer (sodium acetate is recommended by the developer) (L. Technologies 
2013; Lader 2001)⁠. RNAlater works by penetrating sample cells with the ammonium 
sulfate salts and forcing a precipitation of nucleic acids and proteins (Lader 2001)⁠. This 
process is commonly known as ‘salting out’. The salting out process by RNAlater 
deactivates any nucleases found within the cells that would otherwise degrade any 
present nucleic acids (Gorokhova 2005; Lader 2001; Voigt et al. 2015)⁠.  
 RNAlater eliminates many in-field sample storage concerns due to its ease of use 
in the field. According to the manufacturer, collected samples can be placed in certain 
volumes of RNAlater (the amount varies depending on sample material) and frozen once 
cold storage is accessible (Ambion 2014)⁠. For example, utilizing RNAlater for feces 
requires adding 1 mL of RNAlater per gram of feces, mixing, and freezing (Reck et al. 
2015; Zoetendal et al. 2006)⁠. Once placed in RNAlater, samples can be left at room 
temperature for 1 week without jeopardizing sample integrity (Ambion 2014; Reck et al. 
2015)⁠, although standard storage at 4°C, -20°C, or -80°C is eventually necessary to avoid 
molecular degradation. Samples should be submerged in RNAlater overnight at 4°C 
before being transferred to -20°C or -80°C (Ambion 2014). After storage, samples should 
be blotted using a paper towel and gently rinsed to remove RNAlater (fecal samples do 
not receive this step). As stated in the developer manual, samples stored in -20°C or -
80°C preserves samples indefinitely (Ambion 2014)⁠. However, this thesis questions the 
adequacy of these storage lengths.  
 Despite RNAlater’s frequent usage, there are few studies that have examined the 
consequences of RNAlater treatment on data quality (for exceptions see: Choo et al. 
 
4 
2015; Loftfield et al. 2016; Sinha et al. 2016; Wang et al. 2018). Addressed in this thesis 
are three critical questions: How does RNAlater impact metabolomic and 16S RNA gene 
data for functional and microbiome taxonomic characterization, respectively? Does 
RNAlater impact the data diversity measures or bias metabolic and microbial data? And 
lastly, can RNAlater treatment generate both untargeted metabolomic and 16S rRNA 
gene data? 
 
Metabolomics and Anthropology  
 Metabolomics is the study of the total metabolites present and their functional 
roles within a biological system (Bino et al. 2004; Greaves and Roboz 2014; Patti et al. 
2013; Wolfender et al. 2015)⁠. The particular definition of metabolite varies, but in this 
project, metabolites are any small molecule involved in life-sustaining chemical reactions 
(metabolic reactions, or metabolism) whose molecular weight is under 1500 Daltons (Da) 
(Viant et al. 2017)⁠. Due to the vast numbers of atomic arrangements, metabolites have 
high levels of structural variability, especially compared to genes and proteins (Fiehn 
2002)⁠. This extensive assortment of metabolites is generally divided into two categories: 
endogenous and exogenous. Endogenous metabolites are found naturally in organisms 
whereas exogenous metabolites are environmentally acquired (Dawes and Ribbons 2003; 
Wishart 2016)⁠. The total sum of all metabolites is known as the metabolome (Fiehn 2002; 
Patti et al. 2012)⁠. Through studying the metabolome, researchers can explore the 
functional role of metabolites within biological systems (Wolfender et al. 2015)⁠. 
Investigation of these metabolites, and their associated pathways, offers a direct snapshot 
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of the biological phenotype as formed by interactions between the genotype and 
environment (Dettmer et al. 2006; Patti et al. 2012)⁠. This connection to the phenotype 
exists because metabolic reactions are fundamental biological processes (DeBerardinis 
and Thompson 2012)⁠. Thus, metabolites and the metabolome represent the ultimate 
response to genetic and environmental forces (Bino et al. 2004; Nicholson et al. 2011)⁠. 
For example, some human diseases (such as heart disease, diabetes, stroke, and cancer) 
are caused by genetic, lifestyle, and environmental influences (Rattray et al. 2018; Willett 
2002). Studying the metabolome offers a way to thoroughly examine these disease states 
and their associated molecules from all sources of origin, rather than a single cause 
(Rappaport and Smith 2010; Rattray et al. 2018; Willett 2002). 
 Unfortunately, there is no single approach that can completely capture the 
metabolome (Bino et al. 2004; Dettmer et al. 2006; Wishart et al. 2018)⁠. The molecules 
of interest, experimental conditions, instruments, and data analysis approaches are 
variably selected by researchers to best answer their research questions. Depending on 
the project, these conditions can change. One common metabolomics approach involves 
targeted analysis, which focuses on a group of metabolites related to a specific pathway 
or metabolite class (Patti et al. 2012)⁠. A targeted analysis quantifies a known metabolite 
or a small number of metabolites (Wolfender et al. 2015)⁠. On the other hand, untargeted 
screenings categorize analytes depending on a change in response to stimuli and focus on 
measuring as many metabolites as possible (Dunn et al. 2013)⁠. Either approach is equally 
valid at generating metabolomic data and should be selected based on the specific project 
goals. For this project, an untargeted approach was adopted to investigate sample 
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treatment effects on all metabolites found in samples. Such untargeted approaches are 
popular for microbiology and have begun to emerge in molecular anthropology studies 
(Sankaranarayanan et al. 2015; Velsko 2017)⁠. 
 Metabolomics provides critical information for biological anthropologists. 
Biological anthropology can be defined as “the study of human biology within the 
framework of evolution” (Jurmain et al. 2013)⁠. With the popularity of genomics, 
biological anthropologists began studying human biology and evolution through studying 
biochemical molecules like DNA to explore human genetic origins (Ayala 1995), 
compare human microbiomes with chimpanzees and gorillas to track changes during 
human evolution (Moeller et al. 2014), study the relatedness of humans and past 
hominins like Neanderthals (Ovchinnikov et al. 2000), and much more. These new 
molecular anthropologists applied biochemical techniques and technologies to answer 
anthropological questions (Marks 2002)⁠. Recently, molecular anthropological work has 
shifted to studying metabolites. Examples include incorporating targeted MS to study 
hunter-gatherer diets as a proxy for ancient humans (Turroni et al. 2016), medicinal plant 
use by Neandertals (Hardy et al. 2012), and detection of possible metabolites associated 
with longevity in various mammals (Ma et al. 2015). Because metabolomics explores the 
functional role of metabolites, it represents human biology on a molecular level 
(DeBerardinis and Thompson 2012)⁠. This is because metabolites are integral to all 
biological processes, including those of health and disease (DeBerardinis and Thompson 
2012)⁠. Thus, metabolomics has a lot to offer in the exploration of human biology. Despite 
its value to anthropology, metabolomics’s importance has yet to be fully acknowledged 
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within biological anthropology on the same level as genomics. Some molecular 
anthropological studies have conducted metabolomic projects (Radini et al. 2016; 
Sankaranarayanan et al. 2015; Velsko et al. 2017)⁠, but these fields remain young, 
especially with respect to studies that assess the preservation and profile integrity of the 
metabolome in field-based studies.  
 
 
Mass Spectrometry-Based Metabolomics 
 Mass spectrometry (MS) coupled to separation techniques or direct injection 
(Dettmer et al. 2006)⁠ is a common method for metabolomics. Nuclear magnetic 
resonance is also used in metabolomics (Wang and Bodovitz 2010)⁠, but MS is the focus 
here because it was employed for this project. MS can identify, quantify, and analyze 
metabolites found in a sample by generating ionized particles and releasing them into the 
instrument where they are quantified by the detector and subsequently analyzed (Dettmer 
et al. 2006; Greaves and Roboz 2014)⁠. There are varying forms of MS instruments and 
techniques available, but no current process can detect every metabolite in a sample 
(Bino et al. 2004; Zamboni, Saghatelian, and Patti 2015)⁠. Each technique and instrument 
present their own biases in metabolite detection (Greaves and Roboz 2014)⁠. As a result, 
MS-based metabolomics projects can be highly varied in their goals, methods, and 
acquired data (Zamboni, Saghatelian, and Patti 2015).  
 Sample introduction is a critical part of any MS approach, with chromatographic 
separation (CS) being a popular method. Generally, CS separates and transfers sample 
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compounds between two phases to purify the components for identification (Coskun 
2016)⁠. CS coupled to mass spectrometry is generally divided into gas chromatography-
mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS) 
(Dettmer et al. 2006; Patti et al. 2012; Coskun 2016)⁠. CS involves passing samples 
through a column lined with a special solution (called the stationary phase) via the mobile 
phase. This mobile phase can be a gas or a liquid, depending on whether gas 
chromatography or liquid chromatography was employed (Coskun 2016; Greaves and 
Roboz 2014)⁠. Gas chromatography features a gas mobile phase for sample transfer, elutes 
more nonpolar molecules, and is preferred for thermally stable samples (Greaves and 
Roboz 2014)⁠. On the other hand, liquid chromatography utilizes a liquid as the mobile 
phase, elutes more polar molecules, is commonly used for thermally volatile samples, and 
has higher sensitivity for metabolic detection (Coskun 2016; Greaves and Roboz 2014)⁠. 
This greater sensitivity by liquid chromatography is due to its ability to detect molecules 
greater than 600 Da; gas chromatography is less accurate for molecules above this 
threshold (Greaves and Roboz 2014)⁠. Therefore, liquid chromatography is generally 
preferred for untargeted metabolomics. Additionally, some MS instruments include a 
fragmentation step. Such MS instruments utilize tandem mass spectrometry (MS/MS). 
MS/MS fragments ions and detects molecules a second time, allowing for greater 
detection and identification of metabolites (Greaves and Roboz 2014)⁠. For this project, a 
MS/MS instrument called the ThermoScientific Q Exactive Plus Hybrid Quadrupole-
Orbitrap Mass Spectrometer was used to perform untargeted screenings of samples. This 
MS/MS instrument was coupled to a ThermoFisher Scientific Vanquish Flex Binary LC 
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Figure 1. Construction details from the Q Exactive Plus.  
This figure was originally published in Molecular & Cellular Proteomics. Michalski A., 
Damoc E., Hauschild J-P., Lange O., Wieghaus A., Makarov A., Nagaraj N., Cox J., Mann 
M., and Horning S. Mass Spectrometry-based Proteomics Using Q Exactive, a High-
performance benchtop Quadrupole Orbitrap Mass Spectrometer. Mol Cell Proteomics. 
2011; 10:1-11. © The American Society for Biochemistry and Molecular Biology.  
Charged particles travel from the NanoSpray source, through the flatapoles, into the 
quadrupoles for filtering, collect in the C-trap, fragment in the HCD Collision Cell (for 
MS/MS), and enter the Orbitrap Mass Analyzer for detection. 
 
 
System to perform liquid chromatography. These together allowed LC-MS/MS to be 
employed for this project. A brief description of the MS/MS instrument and how it works 




 For this MS model, ions are initially formed via electrospray ionization 
(Scheltema et al. 2014)⁠. Here, sample molecules move through the CS column from the 
Vanquish LC System as a liquid and are dissolved by an electrically charged solvent, 
creating charged ionic droplets (Greaves and Roboz 2014)⁠. These nebulized droplets 
enter the MS/MS instrument and are evaporated to become a gas (Greaves and Roboz 
2014; Michalski et al. 2011; Scheltema et al. 2014)⁠. Ions then pass through the S-lens. 
This is a series of rings serving as an ion transfer tube (Michalski et al. 2011)⁠. Next, the 
ions move through the injection flatapole (which selects out ions) into the bent flatapole. 
The bent flatapole is a series of rods with small gaps between them that allow for droplets 
to fly out of the flatapole (Scheltema et al. 2014)⁠. This design prevents unwanted agents 
from passing further into the instrument (Michalski et al. 2011)⁠. From the bent flatapole, 
ions are channeled into a chamber of four long cylindrical rods called quadrupoles. These 
quadrupoles generate an electric field to guide selected ions along while also filtering out 
unwanted ions (Michalski et al. 2011)⁠. This ion filtering will vary according to the 
experiment. Moving through the quadrupole, ions enter the C-trap and are kept here 
before moving along. This next step moves ions into the HCD collision cell, where they 
are fragmented through collision (Michalski et al. 2011; Scheltema et al. 2014)⁠. This 
fragmentation is what defines MS/MS. After the HCD collision cell, ions are sent back to 
the C-trap before passing through the Z lens. This Z lens leads into the final section of the 
instrument: the orbitrap mass analyzer (Michalski et al. 2011)⁠. The orbitrap is a spindle-
shaped metal rod generating an electrical charge. Ions are fired from the C-trap into the 
orbitrap at high speeds where the electrical force and momentum causes ions to spin and 
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move across the orbitrap (Greaves and Roboz 2014; Fisher Scientific Inc 2016; 
Scheltema et al. 2014)⁠. Due to the spinning and movement of the ions, a ring of 
constantly moving ions is formed around the orbitrap. The size of this ring and the ion 
speed will depend upon the mass-to-charge ratio (m/z) of the molecules. The MS 
instrument detects these rings and subsequently analyzes the fragmented ions (Michalski 
et al. 2011; Scheltema et al. 2014)⁠. Ultimately, the Q Exactive Plus offers highly accurate 
analyte detection and characterization for metabolomic studies (Michalski et al. 2011; 
Scheltema et al. 2014)⁠.  
 Despite its many strengths, MS-based metabolomics has problems ranging from 
database inconsistencies, instrument differences, accurately identifying metabolites, and 
sample treatment and preparation, to name a few (Johnson and Gonzalez 2012; Matsuda 
2016; Patti et al. 2012). These last major weaknesses are highlighted in this thesis: 
sample preparation and treatment. Prior to separation and injection on an MS instrument, 
samples must undergo preparation. This step is crucial in extracting analytes, but it 
results in metabolite losses (Hollywood et al. 2006; Dettmer et al. 2006)⁠. Ultimately, 
sample preparation tends to be where metabolomic experimental errors most frequently 
occur (Fiehn 2002)⁠. These errors commonly include metabolite loss and 
misidentification. Specific losses will vary depending on the preparation techniques 
employed, with solid-phase extraction (SPE) and liquid-liquid extraction as the most 
common sample preparation methods (Dettmer et al. 2006)⁠.  
 Another major problem in MS-based metabolomics is sample treatment. Any 
procedures following sample collection can create biases in the formation, degradation, 
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and detection of metabolites. As a result, sample preservation greatly affects 
metabolomic data. Standard storage methods involve simply snap freezing samples in 
liquid nitrogen or freeze clamping (Fiehn 2002)⁠. However, few studies have explored the 
effects of sample preparation and treatment on metabolomic experiments. Complications 
of sample preservation are further compounded by the inability to use RNAlater (Wang 
et al. 2018)⁠. RNAlater is known to inhibit metabolomic data due to the components of 
RNAlater interfering with the MS instrument and preventing metabolic detection 
(Loftfield et al. 2016; Sinha et al. 2016a; Sinha et al. 2016b; Wang et al. 2018)⁠. 
Particularly, the ammonium sulfate salts are known to be problematic for MS analysis 
(Loftfield et al. 2016; Sinha et al. 2016). Only a handful of studies have used RNAlater 
for metabolomic projects as a result (Loftfield et al. 2016; Sinha et al. 2016; Wang et al. 
2018). This project addresses these preservation concerns with RNAlater and MS-based 
metabolomics in efforts to allow usage of RNAlater for untargeted MS-based 
metabolomic studies through a SPE protocol. These metabolomics data are paired with an 
investigation of RNAlater’s effects on sample integrity through microbiome profile 
analysis.  
 
The Microbiome and Anthropology 
 The microbiome is the collective sum of microorganisms (plus their genetic 
material) living in an environment (Grice and Segre 2012)⁠. For humans, the human 
microbiome is a composite of several microbial communities found in the gut, mouth, 
reproductive tract, and skin (Grice and Segre 2012; Turnbaugh et al. 2007)⁠. Known to 
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number in the trillions, these microorganisms play a variety of biological roles including 
digestion, metabolism, and immunity (Blaser and Falkow 2009; Grice and Segre 2012; 
Turnbaugh et al. 2007)⁠.  
 Human microbiome research elucidates the intersect between genetics, health, 
environment, and lifestyles (Turnbaugh et al. 2007)⁠. Anthropologists have studied the 
human microbiome with growing interest because the microbiome can shed light on our 
species’ evolutionary history, varying diets, behavior, and diversity (Benezra et al. 2012; 
Blaser and Falkow 2009; Vuong et al. 2017)⁠. Such studies can include investigating 
differences between human and non-human primate microbiomes (Moeller et al. 2014; 
Yildirim et al. 2010)⁠, examining historical microbiomes (Tito et al. 2012)⁠, and 
comparisons between human hunter-gatherer and industrialized populations (Obregon-
Tito et al. 2015; Schnorr et al. 2014)⁠. Researchers can utilize microbiome analysis 
methods through DNA sequencing to explore why some bacterial species are no longer 
present, why microbial levels of diversity changed, when these changes occurred, and 
how our relationship with these microbes impacts our biology today. Most common to 
anthropological studies of the human microbiome are rare and extraordinary samples 
retrieved from unique environments and cultural practices (Moeller et al. 2014; Obregon-
Tito et al. 2015; Sankaranarayanan et al. 2015; Schnorr et al. 2014; Turroni et al. 2016; 
Yildirim et al. 2010)⁠. Anthropologists have a legacy of innovating protocols to facilitate 
their often complex and challenging sample conditions (Benezra et al. 2012; Kaestle and 
Horsburgh 2002; Outram 2008; Warinner et al. 2014)⁠. This thesis continues in that same 
spirit, with attention to the microbiome profile via 16S rRNA gene sequencing. 
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The 16S rRNA Gene 
 Species identification is a recurring pursuit within biological sciences (Clarridge 
2004; Pereira et al. 2010)⁠. Early methods for identifying species relied on analyzing 
physical features and comparing these characteristics to those identified by other 
researchers (Clarridge 2004; Woese 1987)⁠. However, these methods are often challenged 
by the subjective and varied nature of examining bacteria for physical characteristics and 
the difficulty in studying unculturable bacteria (Clarridge 2004)⁠. In the 1970s and 1980s, 
the 16S rRNA gene was demonstrated to be more effective at identifying bacterial 
species than these earlier methods (Fox et al. 1977; Woese 1987; Clarridge 2004)⁠. 
Moreover, 16S rRNA gene sequencing provided a way to taxonomically identify 
unculturable bacteria (Amann et al. 1995; Pace 1997)⁠. Advancements in gene sequencing 
have further reinforced 16S rRNA gene sequencing as an ideal technique for 
characterizing bacterial ecologies, such as the gut microbiome (Clarridge 2004; Jovel 
2016)⁠.  
 The 16S rRNA gene, also known as 16S rDNA, encodes for a component of 
prokaryote ribosomes. The 16S rRNA gene is frequently sequenced and studied for 
taxonomic and phylogenetic purposes within microbiol9ogy because it is ubiquitous 
amongst bacteria, has highly conserved regions for targeted PCR-based methods and 
species-specific hypervariable regions for phylogenetic resolution, and is inexpensive and 
easy to sequence (Clarridge 2004; Fox et al. 1977; Kim and Chun 2014)⁠. In particular, the 
conserved and hypervariable regions make 16S rRNA gene sequences superior to earlier 
phenotype-based phylogenetic methods (Pace 1997)⁠. By aligning different organisms’ 
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16S sequences, researchers can count nucleotide differences as a measure of evolutionary 
distance between the organisms (Amann et al. 1995; Pace 1997)⁠. Thus, researchers can 
employ 16S rRNA gene sequences to understand how prokaryotic evolution occurred, 
what species are related to each other, and when species might have diverged through 
established methods in phylogenetics. While the gene’s conserved and hypervariable 
regions make it an excellent molecular clock for measuring this evolutionary distance 
(Tsukuda et al. 2017)⁠, the 16S rRNA gene sequence is limited at identifying closely-
related species or within-species strains (Jovel 2016; Kolbert and Persing 1999)⁠, such 
phylogenetic studies often require more multi-loci or genome studies, which exceed the 
resource of this thesis. Nevertheless, 16S rRNA gene-based studies remain the most 
prolific of phylogenetic approaches to microbiology in general, and microbiome 
specifically, in the last 30 years. 
 A 16S rRNA gene approach does not replace or diminish the importance of 
culture-based methods. While phenotypic species identification methods were limited in 
their ability to characterize unculturable bacteria, it has its advantages for culturable 
bacteria (Clarridge 2004)⁠. Chemotaxonomy, a combination of phylogenetics and culture-
based approaches to functional characterization of bacteria, remains a common practice 
for identifying novel species, and thus, culturing methods remain critical to the study of 
microbial variation (Clarridge 2004; Prakash et al. 2007)⁠. This combination of 
phenotypic and genotypic information for taxonomic purposes is called polyphasic 
taxonomy (Prakash et al. 2007; Vandamme et al. 1996)⁠. Such polyphasic approaches are 
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common in microbiology studies and frequently generate taxonomic inventories of 





MATERIALS AND METHODS 
 This research was conducted at the University of Oklahoma Norman Research 




 All samples for this project were human fecal samples gathered from villages in 
Burkina Faso, Africa. A total of 120 individuals from 30 families (four from each family) 
contributed samples. Informed consent was provided with oversight from the Ministry of 
Health Ethics Committee located within Centre Muraz, a Burkina Faso national research 
institute. Participants were equipped with a labeled disposable collection container and a 
pair of gloves. The collection container and fecal sample were returned to researcher on 
site. Multiple scoops of sample were placed in collection tubes and these tubes were 
sealed then placed in a labeled bag. Bags were sealed and placed in ice located on-site. 
Next, samples were transferred to a -20°C freezer for overnight storage. All processing 
took place within 15 minutes. Each evening, samples were thawed prior to DNA 
extraction. DNA was extracted then samples were frozen again. Sampling occurred in 
this manner over the course of several days. After sample collection, all frozen samples 
were shipped to LMAMR at Norman, Oklahoma, and stored in a -80°C freezer. Samples 
were briefly thawed again to extract 2g from each sample for anaerobic culturing. After 
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the 2g collection, samples were kept frozen in -80°C until treatment for this project. Ten 
of these 120 total samples were used for this project. 
 
Experimental Design  
 The design and sample treatment of this project can be grouped into two distinct 
stages for metabolomics. Stage two was a modification of stage one, but the same 
samples were used for the entirety of the project.  
 Ten samples with the largest mass were chosen and set aside for this project. Four 
grams (g) of each sample was aliquoted, which were the working samples for this project. 
Of each 4g sample, 1g was removed sequentially as subsamples and stored in -80°C. 
These 1g subsamples were frozen backups in case more samples were needed. The 
remaining 3g of each sample was then divided into two separate groups of 1.5g each. One 
1.5g group was designated as raw, untreated samples. The second 1.5g group was 
allocated for treatment with RNAlater. Each 1.5g group (totaled at 20 separate 1.5g 
groups, 10 without RNAlater and 10 with RNAlater) were then further aliquoted into 
three distinct 0.5g portions. This created a total of 60 working sample, with six 
subsamples per sample. Of these six subsamples per sample, a total of three were 
untreated and the other three were treated with RNAlater. Thus, 30 total untreated and 30 
RNAlater samples were used for this project.  
 Following this treatment, the six subsamples from each sample were sorted into 
temperature groups: -80°C, 4°C, and room temperature (22-25°C). These temperatures 
were chosen because they are common storage temperatures for metabolomic samples 
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(Dettmer et al. 2006)⁠. Two of the six subsamples were placed in each temperature group, 
creating two in -80°C, two in 4°C, and the last two in room temperature. These samples 
were stored in their respective temperature groups for two weeks. Within these 
temperature groups, one subsample was untreated, and the other was RNAlater-treated. 
These steps were repeated for each sample. In the end, the 60 total samples (six each 
from the ten original samples) had 20 0.5g aliquots in each of the three temperature 
groups. Half of these 20 were untreated while the other half were RNAlater-treated. 
Figure 1 depicts this experimental design.  
After two-week storage, RNAlater samples underwent a RNAlater cleanup 
protocol designed to remove RNAlater components which impact MS analysis. Stage one 
samples were subjected to the RNAlater cleanup protocol twice to maximize RNAlater 
removal and avoid contaminating the MS instrument. Non-RNAlater samples did not 
undergo this protocol and, instead, were prepared for MS immediately after the two-week 
storage. Following RNAlater cleanup, samples were prepared for MS analysis then 
stored in -80°C prior to MS analysis. Remaining sample material was kept at -80°C. This 
concludes stage one of the project.  
 Stage two tested the efficacy of undergoing RNAlater cleanup two times. Of the 
30 available RNAlater-treated 0.5g samples, seven random samples were chosen and set 
aside for further RNAlater cleanup. Samples in stage two were treated identically to 
those from stage one except the stage two samples only underwent one RNAlater cleanup 
protocol. Following the single RNAlater removal, samples underwent the same 
metabolomic workflow as stage one. Stage one and two were run as separate batches on 
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the MS instrument. A minimal number of RNAlater samples (12 total, including blank) 
were run on the MS instrument to ensure traces of RNAlater would not negatively affect 





Figure 1: Experimental Design.  
Simplified visualization of metabolomics experimental design described previously. For 
stage one, samples went through SPE again following elution. For stage two, samples 
went through SPE once. Samples were loaded onto a Vanquisher LC system which 








Solid-Phase Extraction: RNAlater Cleanup 
 In this study, the RNAlater cleanup protocol was optimized from a SPE protocol 
presented by Cottrell et al. 2015. An Oasis Waters extraction manifold (20 pos, 13x75mm 
tubes, cat.: WAT200606) connected to a Rocker 400 650mmHg vacuum pump (cat.: 
167400–11) were used for SPE. Oasis Waters SPE HLB 1cc Vac Cartridges (10 mg 
sorbent per cartridge, 30μM particle size, cat.: 186000383) were placed in the extraction 
manifold. Flow rate was adjusted to approximately 1 drop per second, as per Oasis 
Waters SPE protocol. Vacuum pressure and flow rate varied depending on the sample 
buffer, necessitating frequent manual adjustment of the flow rate to match the 1 drop per 
second ideal. LC-MS grade water and LC-MS grade methanol were always used for 
RNAlater cleanup protocol unless otherwise specified. 5mL culture tubes were used to 
collect flowthrough and were replaced after each cartridge loading.  
 To prepare RNAlater-treated samples, RNAlater was added to create in a 1:1 
ratio of RNAlater to sample. In this sample type, 0.5g of feces were combined with 500μl 
of RNAlater was added to each of these samples. Following RNAlater addition, all 
samples were mixed with volumes of water spiked with 2μM sulfachloropyridazine as 
internal standard (IS) to reach a total volume of 5mL. This resulted in 4.5mL of water. 
For the untreated samples, 5mL of water was used. All samples were then homogenized 
by sonication to create fecal slurries.  
 Samples were placed in a FisherScientific Ultrasonic Cleaning Bath (20.8L, cat.: 
15-337-435) at maximum power for 10 minutes. Following sonication, samples had 
organic and supernatant layers. 1000μL of supernatant from each RNAlater-treated 
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sample were collected and placed in separate, appropriately labeled 1.5mL collection 
tubes prior to SPE. 1000μL of supernatant from each of untreated samples were collected, 
placed in new 1.5mL collection tubes, and set aside. The original samples were then 
placed in -80°C for storage. From here, only the supernatants of the RNAlater-treated 
samples underwent the following steps. 
 Next, samples were centrifuged at 14,000rpm at 4°C for 10 minutes using an 
Eppendorf 5242 mini-centrifuge (cat.: 0008643) in a freezer room. Oasis Waters SPE 
HLB cartridges were rinsed with 3mL methanol and 3mL water to condition and 
equilibrate the cartridges under vacuum. After all liquid flowed through, 1000μL of 
samples were each loaded into cartridges under vacuum. Next, 3mL from each of the 
following were added to every cartridge under vacuum in this order: water, 5% methanol, 
50% methanol with 0.1% acetic acid, and 50% methanol. All liquid flowed through the 
cartridges before adding the subsequent solution. Cartridges were then vacuum-dried to 
remove any remaining liquid. Next, 1mL methanol was added for elution with new 1mL 
collection tubes placed to collect eluates, yielding 1000ul of eluate for each sample. For 
stage one, this RNAlater cleanup was repeated using the new eluates. New SPE 
cartridges were put in place and the steps were identical to previous RNAlater cleanup 
with the eluates used for sample loading. Stage two moved on to next step of MS 
treatment.  
 Following final elution from RNAlater cleanup, elutes and 1000μL of supernatant 
from untreated samples were placed in an Eppendorf Vacufuge Vacuum Concentrator 
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(cat.: 005535). Dessicator function was utilized to dry down samples for MS analysis. 





1) Add 500μl of RNAlater to 0.5g aliquots of raw fecal samples. Do not add to non-
RNAlater samples. Add 4L of LC-MS grade water (spiked with IS) to RNAlater 
samples. For non-RNAlater samples, add 4.5L instead. Total volumes should be 5L. 
a) All following reagents and solutions should be LC-MS grade.  
2) Homogenize to create slurries. Place in sonicator at maximum power for 10 minutes. 
3) Take 1000μl of aqueous supernatant and place in separate tubes. Remaining samples 
should be stored in -80°C as backup. Set aside supernatants from non-RNAlater 
samples. Only RNAlater supernatants should undergo the following steps. 
4) Centrifuge at 14,000rpm at 4°C for 10 minutes.  
5) During or after centrifugation, place SPE cartridges into SPE extraction manifold. 
One cartridge per sample. Place collection tubes (we used culture tubes) in the 
interior manifold tube rack to collect waste.  
6) Rinse each SPE cartridge with 3mL methanol, followed by 3mL water. Cartridges are 
now conditioned and equilibrated. 
a) Replace waste tubes following each added reagent to cartridge. 
7) After centrifugation, load all 1000μL of sample supernatant into cartridges.  
8) Add 3mL of methanol to each cartridge. 
9) Add 3mL 5% methanol to each cartridge. 
10) Add 3mL 50% methanol with 0.1% acetic acid to each cartridge. 
11) Add 3mL 50% methanol to each cartridge. 
12) Vacuum-dry cartridges for 5 minutes. 
13) Place empty 1mL collection tube in interior tube rack. Add 1mL methanol to each 
cartridge for elution.  
14) For second RNAlater removal, elutes from Step 11 were treated as new samples and 
protocol was restarted from Step 4. 
15) After final elution, place RNAlater-removed elutes and 1000μL from untreated 
samples inside Vacufuge. Activate dessicator function to dry down samples for MS 
analysis. 
16) Once liquid is dried, place samples in -80°C until ready for MS analysis. 
 
Table 1.  RNAlater Removal Protocol.  
Our optimized RNAlater cleanup protocol is listed here. The protocol is a normal-phase SPE procedure 
developed from a similar protocol used by Cottrell et al. 2015. Goal is to isolate and remove the RNAlater 
salts from samples without removing metabolites. SPE works by having target molecules bind to a silica 
sorbent within the cartridge, wash the sorbent, and then elute the target analytes. Chemicals and reagents 
used for SPE should be selected based off their chemical properties and the properties of the target 
analytes. For this RNAlater removal SPE protocol, all solutions and reagents should be LC-MS grade. 
Only samples treated with RNAlater should undergo steps 4-14. 
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Liquid chromatography-tandem mass spectrometry 
 All LC-MS/MS processing was done using the ThermoFisher Scientific Vanquish 
Flex Binary LC System (cat.: IQLAAAGABHFAPUMBJC) linked to the ThermoFisher 
Scientific Q Exactive Plus Hybrid Quadrupole-Orbitrap Mass Spectrometer (cat.: 
IQLAAEGAAPFALGMBDK). These instrument performed LC and MS/MS, 
respectively. Samples were removed from -80°C and resuspended using 200μL of 50% 
LC-MS grade methanol spiked with 0.5μg/mL sulfadimethoxine as an IS. After 
resuspension, samples were added to a 96-well plate for MS injection. Resuspended 
samples were injected with an injection volume of 20μL. A Kinetix C18 core-shell 
column (50x2.1mm, 1.7μM particle size, 100 Å pore size, cat.: 00B-4475-AN) was used 
for LC. The mobile phase consisted of two solvents: Solvent A as LC-MS grade water 
with 0.1% formic acid and Solvent B as LC-MS grade acetonitrile with 0.1% formic acid. 
To avoid RNAlater components from entering MS instrument, flow was initially directed 
to waste for 30 seconds and 15 seconds for samples from stages one and two, 
respectively. This common step prevents contaminating the MS source with unwanted 
molecules from the mobile phase. After this initial waste redirection, gradient parameters 
were 5% Solvent B for 1 minute, increase from 5%-100% Solvent B over 8 minutes, 
remain at 100% Solvent B for 2 minutes, decrease to 5% Solvent B for 30 seconds, and a 
1 minute re-equilibration phase at 5% Solvent B. Column temperature and compartment 
were kept at 40°C and 10°C, respectively, during analysis. For samples from stage one, 
samples were randomly selected for injection in order to test effects of RNAlater removal 
on MS. All stage two samples were injected in order of location on 96-well plate. 
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 Electrospray ionization parameters were: sheath gas flow rate at 35 L/min, 
auxiliary gas flow rate at 10 L/min, auxiliary gas temperature at 350°C, and sweep gas 
flow rate at 0 L/min. S-lens RF was at 50V, spray voltage was at 3.8 kV, and the capillary 
temperature was at 320°C. MS data were acquired in positive mode, with data-dependent 
acquisition for MS2 data. MS scan ranges were set to 100-1500 m/z. 5 MS/MS scans of 
the most abundant ion per cycle were recorded. MS1 resolution was set to 35,000 and 
MS2 resolution was set to 17,500. MS1 and MS2 maximum injection time were both set 
at 100 ms. MS AGC target was at 1e6 and MS/MS AGC target was at 5e5. 2m/z was 
used as an isolation window. MS/MS occurred at 2-8 seconds with an exclusion of 10 
seconds. Collision energy was increased from 20% to 30% and to 40%.   
 
16S rRNA Gene Amplicon Sequencing 
 To illustrate bacterial taxonomic profiles, the bacterial 16S rRNA gene V4 
hypervariable region was targeted and amplified. 16S amplification and sequencing was 
performed on all samples following sonication after addition of RNAlater. As mentioned 
earlier, a total of 60 samples were utilized in this project. These 60 samples underwent 
the same 16S procedures, regardless of temperature or RNAlater treatment. None of the 
samples used for 16S rRNA gene sequencing underwent the RNAlater removal protocol.   
 DNA was extracted using the Qiagen AllPrep PowerViral DNA/RNA Kit 
(cat:28000-50) with extraction blanks. Extraction protocol followed manufacturer 
instructions. Final DNA concentration was quantified using the Invitrogen Qubit 2.0 
Fluorometer (cat.: Q32866) with the ThermoFisher Scientific Qubit dsDNA Broad Range 
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assay kit (cat.: Q32850). See supplementary table 1 for these Qubit results. Samples 
underwent this DNA extraction procedure in batches of ten with one negative blank in 
each batch, causing the final sample count for 16S rRNA gene sequencing to be 66 total 
samples (60 samples with 6 negative blanks). These 66 samples all underwent the 
following steps.  
   16S copy number quantification was collected via quantitative polymerase chain 
reaction (qPCR). The Roche FastStart Essential DNA Green MM with SYBR Green I 
was used (cat.: 06402712001) on a Roche Lightcycler 96 (cat.: 05815916001). 10μM V4 
non-Illumina primer stocks of 515f (GTGCCAGCMGCCGCGGTAA) and 806r 
(GGACTACHVGGGTWTCTAAT) were used as forward and reverse primers, 
respectively. qPCR negative blanks were included. In-house Escherichia coli (E. coli) 
standards (1000x, 100x, 10x 16S copies per μL) were used as positive controls and 
standards. Initial denaturation was set to 95°C for 10 minutes, with 35 cycles at 95°C for 
10 seconds, 52°C for 20 seconds, and 72°C for 30 seconds. Samples were diluted and 
categorized into two PCR groups according to qPCR results.  
 16S triplicate PCR was performed with negative and positive controls using the 
ThermoFisher Scientific Phusion HotStart II High Fidelity DNA Polymerase Enzyme 
System (cat.: F-549L) on an Analytik Jena Biometra T Professional Trio Thermocycler 
(cat.: 3408114).  10μM stocks of the universal 515f V4 primers with Illumina adapters 
were used in all samples. 2.5 μM stocks of 806r V4 barcoded primers with Illumina 
adapters were similarly employed. These universal reverse primers had unique 12bp 
GOLAY error-correcting barcodes for multiplexing (Caporaso et al. 2012). Each sample 
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was given a unique reverse primer and barcode. Supplementary table 3 depicts these 
sample-to-barcode matches. UV nanopure water used for PCR blanks instead of DNA 
template. Supplementary table 4 depicts the PCR reaction sheet used, including amount 
of each reagent. PCR conditions were initial denaturation at 98°C for 30 seconds, 18 (for 
PCR group 1) or 20 (for PCR group 2) cycles of 98°C for 15 seconds, 52°C for 20 
seconds, 72°C for 30 seconds, and final extension at 72°C for 5 minutes.  
 Sample triplicates were pooled, and the pools were purified using the Qiagen 
MinElute PCR Purification kit (cat.: 28004) according to the Qiagen protocol. Sample 
pools were run on a 1% agarose gel and desired fragments (~380 bp) were cut from gel. 
Excised gel fragments underwent the Qiagen QIAquick Gel Extraction kit (cat.: 28706) 
following kit instructions. Pools were normalized to 4nM, denatured using 0.5N NaOH, 
and diluted to a final concentration of 10pM. 15% PhiX control was added to sequencing 
pool. Final pool was loaded onto an Illumina MiSeq Next Generation Sequencer (cat.: 
SY-410-1003) using the Illumina MiSeq Reagent 2x250bp v2 Kit (cat.: MS-102-2003) 
protocol. All 60 working samples, six extraction blanks, two PCR blanks, and two E. coli 
10X positive controls (totaling 70 samples) were loaded onto the MiSeq as the loading 
pool. These were the only samples on this MiSeq run. 
 
Data Analysis 
 Raw MS and MS/MS files were converted to mzXML format using MSConvert 
(Chambers et al. 2012). MZMine v2.37 was used to identify MS features (Pluskal et al. 
2010). MZMine parameters are depicted in supplementary table 5. PCoA plots were 
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created using a Canberra distance matrix with the ClusterApp online program 
(http://dorresteinappshub.ucsd.edu:3838/clusterMetaboApp0.9.1/). Molecular networking 
and library spectral database searches were completed using the Global Natural Products 
Social Molecular Networking (Wang et al. 2017), also known as GNPS, on the mgf file 
exported from MZMine. As GNPS only works with MS/MS data, only the MS/MS files 
were uploaded. GNPS parameters were: precursor and fragment ion mass tolerance: 0.02 
Da, minimum cosine score for networking and library matches: 0.7, minimum number of 
matched MS2 fragment ions for networking and library matches: 4, network topK: 50, 
maximum connected component size: 100, maximum shift between precursors: 500 Da, 
analog search: enabled, maximum analog mass difference: 100 Da, precursor window 
filtering: enabled, 50 Da peak window filtering: enabled, normalization per file: row sum 
normalization. Results were analyzed by evaluating mirror plot similarity, cosine score, 
and plausibility of matches. 
16S rRNA gene sequences were downloaded from Illumina BaseSpace sequence 
hub (http://basespace.illumina.com). Raw file outputs gave a unique Sample ID with 
three numbers (e.g.: Samp254). These were matched to the RCBC number corresponding 
to the unique reverse barcode for each sample and utilized for demultiplexing. 
AdapterRemoval v2 (Schubert et al. 2016) was used to trim and merge Read1 and Read2 
files with a quality score equal to or greater than 30 phred. Next, these files were 
collapsed into a single file containing all the merged reads. Quantitative Insights Into 
Microbial Ecology 1 (QIIME 1) was employed for operational taxonomic unit (OTU) 
picking (Caporaso et al. 2010). Closed-reference OTU picking was performed using the 
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EzTaxon Database (Chun et al. 2007) to identify taxonomy and generate a biom file. This 
OTU picking method was selected because it uses reference sequences for alignment, 
which allows faster speed, high-quality taxonomic selections and phylogenetic trees, and 
nonoverlapping amplicons can be compared (Rideout et al. 2014).  
Summarizing the biom file revealed all working samples and E. coli standards 
contained at least 12,000 reads. None of our negative controls contained 12,000 reads, so 
12,000 was selected as the rarefaction depth. Following rarefaction, phyla and genera 
level taxonomy of the remaining 60 samples and two E. coli standards were processed 
using Microsoft Excel to calculate the relative frequencies and abundances of bacterial 
taxa. The top five most abundant phyla and top fifteen genera were identified and plotted 
using Microsoft Excel. 
For alpha diversity analysis, a phylogenetic tree was generated using the EzTaxon 
Database (Chun et al. 2007). MAFFT (Katoh and Standley 2013) was used to align 
sequences within a mapping file containing a single representative sequence for each 
OTU. Next, FastTree (Price, Dehal, and Arkin 2009) was used within QIIME to generate 
phylogenetic trees based off the aligned OTU sequences. QIIME then generated alpha 
diversity results from the rarefied biom file and phylogenetic tree. Average abundance of 
specific taxa was calculated by summing up the total taxa within each sample and 
dividing the count for each taxon by the total amount. Alpha diversity analyses focused 
on the top five abundant phyla and top 15 abundant genera across all samples. For beta 
diversity, QIIME was employed to create unweighted and weighted UniFrac distance 
matrices. These correspond to presence/absence and abundance of bacterial taxa, 
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respectively. Next, Principal Coordinate Analysis (PCoA) using these UniFrac distance 
matrices, as implemented in QIIME, was performed, followed by utilizing Emperor 
within QIIME to generate three-dimensional PCoA plots. Additional analysis was 
performed in R version 3.5.3 (R Core Team 2018) using the R package ggplot2 to create 
boxplots, scatter plots, and two-dimensional PCoA plots (Wickham 2016). Statistical 
significance of results was determined using the FSA package in R to perform the 
Kruskal-Wallis test by ranks and Dunn’s test on alpha diversity files (Ogle 2017). Dunn’s 
test was employed to validate the findings from significant Kruskal-Wallis tests. Analysis 
of covariance (ANCOVA) was done in R to test the effects of treatments while 
controlling for covariates on alpha diversity files. Permutational multivariate analysis of 
variance (PERMANOVA) was used in QIIME to evaluate statistical significance of beta 
diversity data. Results from these statistical tests can be found in supplementary table 6. 
The data from these taxonomic summaries, alpha diversity, and beta diversity analyses 








 While we were able to successfully employ a RNAlater cleanup protocol to 
generate untargeted LC-MS/MS data, our RNAlater cleanup protocol did not appear to 
preserve metabolomic profiles. The internal standards (sulfachloropyridazine and 
sulfadimethoxine) were detected, but GNPS spectral library searches identified six total 
metabolites (not including internal standards) across all samples and stages. Generally, 
MS-based metabolomics projects have several hundred total identified metabolites, with 
ranges including 180-860 metabolites depending on the project and its goals (Loftfield et 
al. 2016; Sankaranarayanan et al. 2015; Turroni et al. 2016; Wang et al. 2018)⁠. Since only 
six metabolites were detected for this project, this indicates metabolomic profiles within 
samples were not preserved properly. This was true for all samples ran on the MS, 
irrespective of the number of RNAlater removals performed.     
 While the GNPS spectral library search detected six total metabolites, only one 
compound was a proper match based on mirror plot similarity (Figure 3) and cosine 
score: urobilinogen. According to the Human Metabolome Database, urobilinogen is a 
parent compound of the pigment stercobilin, which is known to give feces its color 
(Wishart et al. 2018). Since urobilinogen is a fecal metabolite, its presence within our 
samples is expected. However, urobilinogen was only detected in seven samples. Of 
these seven total samples, five samples had a single RNAlater removal.  
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Figure 3. Mirror plot of Urobilinogen from GNPS. 
This screenshot was taken from the GNPS website. In GNPS, mirror plots are used to evaluate whether 
a match from the spectral library database is valid. The bottom bars in green are the raw peaks 
associated with the matched molecular from the GNPS library. The top black bars are the peaks from 
the users’ submitted data that GNPS believes are a mach. Both sets of peaks are placed on top of each 
other to easily identify if they match. The size and placement of peaks must be similar for the match to 
be considered valid. In this case, the peaks from our data and the library data are nearly identical. 
Therefore, this molecular is a valid match to our data.  
 PCoA plots generated using Canberra distance matrices demonstrate that while 
we were unable to preserve metabolomic profiles, sample treatment still influenced our 
metabolomic content (Figure 4A). Samples that underwent two RNAlater cleanups 
clustered very tightly together, whereas one-time RNAlater removal samples did not 
cluster together as strongly. Also, these plots do not show clustering according to storage 
temperature (Figure 4B). Furthermore, these PCoA plots did not position our negative 
blank near any of our samples (Figures 4A and 4B). This indicates samples were not 
completely devoid of metabolites, even though the entire metabolomic profile was not 
preserved. 
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Figure 4. Three-dimensional PCoA plots of metabolomics samples. Generated from 
Canberra distance matrices. 
(A) Color-coded number of RNAlater cleanups by: dark blue samples (2 RNAlater cleanups), 
green samples (1 RNAlater cleanup), and tan (blank, 0 RNAlater cleanup). Samples that had 
two RNAlater cleanups clustered together very tightly. On the other hand, samples that 
underwent a single RNAlater removal did not group together as strongly. These samples 
clustered in the same general area of the PCoA plot, but did not occupy the same space, unlike 
the samples that underwent two RNAlater cleanup protocols. Negative blank located at bottom 
indicates RNAlater removal did not deplete all metabolites from samples. 
(B) Color-coded storage temperature by: green (NA, blank), tan (room temperature, 22-25°C), 
silver (-80°C), and red (4°C). Samples did not readily cluster due to temperature. The group of 
clustered -80°C samples were all samples that went through two RNAlater cleanups, which 
likely caused the clustering.  
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Gut Microbiome Profile 
 DNA from all 60 samples was successfully extracted, amplified, and sequenced. 
Of the total 12,588,428 reads from the Illumina MiSeq, 11,704,428 reads passed filtering 
criteria. Approximately 25% of these passing filter reads mapped to our PhiX control 
according to the MiSeq, resulting in a total 7,765,530 16S reads identified as the samples 
in this study.     
 Microbiome taxonomic inventories were first investigated by identifying the most 
abundant phyla within samples. Samples exhibited high levels of the phyla Firmicutes 
(76.6% average abundance), Actinobacteria (14.6% average), Bacteroidetes (3.3% 
average), Proteobacteria (2.5% average), and Euryarchaeota (1.3% average). These 
specific phyla are the most abundant across all samples (Figure 5). Other identified phyla 
include Tenericutes, Cyanobacteria, Verrumicrobia, and more (Supplementary table 7A). 
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Sample names can 
be broken down into 
host, storage 
temperature, and 
RNAlater. The first 
four numbers refer 
to the family number 
and individual 
within that family 
(e.g.: 0702= family 
07, family member 
02).  These are 
always individuals. 
RT/4/80 refer to 
storage at room 
temperature (RT), 
4°C (4), and -80°C 
(80), respectively. 
The final letter, N/R, 
refers to use of 
RNAlater. N means 
No and R means 
RNAlater (Yes). For 
example, sample 
0901RTN is from 
family 09, family 
member 02, stored 
at room temperature, 






Next, the top 15 most abundant genera were identified (Figure 6). These top 
genera include Blautia (10.3% average abundance), Clostridium (8.3% average), 
Collinsella (6.4% average), Subdoligranulum (4.1% average), and Pediococcus (3.6% 
average), to name a few (Supplementary table 7B). Overall, the distribution of genera 
was highly varied within these samples. For phyla, all samples generally had the same top 
five abundant phyla with only a small percentage of other phyla (such as Tenericutes or 
Cyanobacteria). At the genus level, samples usually contained many more genera outside 
the top 15, showing a greater range of taxa within samples. Of the top 15 most abundant 
genera, 12 belonged to the phylum Firmicutes. After characterizing the bacterial 
taxonomic inventories of our samples, the bacterial diversity within samples was then 
explored. 
Alpha diversity analysis of samples indicates the use of RNAlater affected 
phylogenetic diversity and microbial richness within samples. RNAlater-treated samples 
generally had higher counts of observed bacterial species (Figure 7A) and increased 
phylogenetic diversity (Figure 7B). When examining samples based on the individual 
sample donor, the RNAlater samples exhibited higher microbial richness and 
phylogenetic diversity compared to non-RNAlater samples from the same host. The 
Kruskal-Wallis test by ranks followed by Dunn’s test confirmed this observation was 
statistically significant (both p-values=0.01). Furthermore, alpha diversity analyses also 
demonstrated that sample taxonomic inventories were largely impacted by the host 
sample donor. For both microbial richness and phylogenetic diversity, host-based 
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Figure 7. Boxplots of alpha diversity analyses. 
Color-coded RNAlater use by: green (No) and red (Yes). Non-RNAlater samples tended to show wider 
ranges of diversity. 
(A) Microbial richness of samples from all hosts increased in RNAlater samples. Number of observed 
species varied dramatically between hosts. 
(B) Phylogenetic diversity of samples from all hosts generally increased in RNAlater samples. Number of 
observed species for each host were very different. Trends exhibited here are like those from Figure 7A. 
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Despite these observations from RNAlater and individual sample donors, there 
were no significant differences in microbial richness or phylogenetic diversity due to 
storage temperature (p-values=0.62 and 0.53, respectively). RNAlater samples exhibited 
increased microbial richness (Figure 8A). When examining the effects of storage 
temperature in alpha diversity analyses without considering RNAlater use, all 
temperatures had relatively equal values for microbial richness and phylogenetic diversity 
(Figure 8B). However, inspecting both temperature and RNAlater use together reveals 
that non-RNAlater samples stored at room temperature had decreased microbial richness 
and phylogenetic diversity (Figure 8C).  
Beta diversity analyses report that differences between samples were primarily 
due to host. PCoA plots using both weighted and unweighted UniFrac distances 
demonstrate strong clustering based on host donor (Figures 9 and 10, respectively). After 
utilizing PERMANOVA on both weighted and unweighted UniFrac distance matrices 
(weighted p-value=0.001, unweighted p-value=0.001), these differences were found to be 
statistically significant.  However, seven samples did not cluster due to individual donor 
based on weighted UniFrac distances (Figure 9B). Instead, these seven samples all did 
not receive RNAlater treatment and were kept at room temperature. Interestingly, five of 
the seven outliers contained the genus Pediococcus in high abundance (Figures 6, 10, 11, 
12, 13, and Table 2). These five samples had the highest levels of Pediococcus 
abundance from any sample, and it was the most abundant genus in these five samples. 
PCoA plots using unweighted UniFrac distances do not show these seven outliers 
(Figures 10A and 10B).  
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 Figures 9 and 10 illustrate samples did not cluster according to RNAlater use or 
storage temperature (except for the seven outliers). Nevertheless, PERMANOVA 
analysis indicates RNAlater use (weighted p-value=0.001, unweighted p-value=0.002) 
and storage temperature (weighted p-value=0.001, unweighted p-value=0.001) caused 
statistically significant differences between samples. Therefore, individual sample donor 
was the primary force affecting differences between samples, but RNAlater and storage 
temperature slightly affected microbiome profiles. These effects were outweighed by the 





















Figure 8. Boxplots of alpha 
diversity analyses by sample 
treatment method. 
Alpha diversity analyses of storage 
temperature and RNAlater use. 
(A) Color-coded RNAlater use by: 
green (No) and red (Yes).  
RNAlater-treated samples had 
increased microbial richness, 
although non-RNAlater samples 
had a wider range.  
(B) Color-coded storage 
temperatures by: green (4°C), red (-
80°C), and blue (room temperature, 
22-25°C). All storage temperatures 
exhibited similar microbial 
richness.  
(C) Color-coded RNAlater use by: 
light blue (No) and dark blue (Yes). 
Storage temperature on x-axis. 
Microbial richness was relatively 
similar for samples regardless of 
treatment method. However, 
RNAlater samples displayed 
increased microbial richness 
regardless of storage temperature. 
The exceptions are non-RNAlater 
samples kept at room temperature, 
where these samples exhibited 




Figure 9. Two-dimensional PCoA plots using unweighted UniFrac distances.  
Color-coded individual by: red (702), orange (901), brown (1001), dark green (1002), light green 
(1102) teal (1301), sky blue (2001), dark blue (2302), purple (2401), and pink (3002). These PCoA 
plots were generated from beta diversity analyses used to create unweighted UniFrac distance 
matrices. Differences in presence and absence of taxa were primarily due to host. Samples generally 
clustered with other samples from their host. Moreover, host clusters were occasionally distinct from 
each other rather than packing together closely. 
(A) Shape-coded RNAlater use by: circle (No) and triangle (Yes). Differences in presence and absence 
of taxa were primarily due to host rather than RNAlater use. Samples did not appear to cluster due to 
the usage of RNAlater.  
(B) Shape-coded storage temperature by: circle (4°C), triangle (-80°C), and square (room temperature, 
22-25°C). Unweighted UniFrac plots show samples generally clustered according to host instead of 
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Figure 10. Two-dimensional PCoA plots using weighted UniFrac distances. 
Similar to Figure 6 except these plots were created using weighted UniFrac distance matrices. Color-
coded individual by: red (702), orange (901), brown (1001), dark green (1002), light green (1102) teal 
(1301), sky blue (2001), dark blue (2302), purple (2401), and pink (3002). While samples generally 
clustered based on host differences, almost all the samples were packed tightly together in a large 
group. There is much more overlap between hosts than in the unweighted PCoA plots.  
(A) Shape-coded RNAlater use by: circle (No) and triangle (Yes).This PCoA plot shows how samples 
primarily clustered according to host when examining differences between abundance of taxa. 
RNAlater use had little effect on clustering. However, within host groups, there appeared to be slight 
clustering due to RNAlater.  
(B) Shape-coded storage temperature by: circle (4°C), triangle (-80°C), and square (room temperature, 
22-25°C). Host differences affecting the abundance of bacterial taxa drove sample clustering more 


























Figure 11. Two-dimensional PCoA plot from 
weighted UniFrac distances with storage 
temperature and RNAlater.  
Shape-coded storage temperature: circle (4°C), 
triangle (-80°C), and square (room temperature, 
22-25°C). Color-coded RNAlater use by: red 
(No) and blue (Yes). This PCoA plot using 
weighted UniFrac distance matrices shows 
samples largely do not cluster according to 
storage temperature or RNAlater use. However, 
this plot highlights the seven outliers located in 
the lower right half of the plot. These outliers 
are the only points between 0.0 & 0.2 PC1 and 
0.0 & -0.2 PC2. The seven outliers clustered 
closer to each other than to other samples from 
their hosts. Five of these outliers had high levels 
of Pediococcus. Clearly the sample treatment 














Table 2.  Seven weighted UniFrac outliers.  
Five of these seven outliers showed Pediococcus 
at high abundance, especially compared to other 
samples. For these each of these five samples, 
Pediococcus was the most abundant genus.   
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Figure 12. Three-dimensional PCoA biplot from weighted UniFrac with genera added.  
Color-coded individual by: red (blank), dark blue (0702), orange (0901), green (1001), purple 
(1002), yellow (1102), light blue (1301), pink (2001), teal (2302), brown (2401), and grey (3002). 
Semi-transparent gray clouds correspond to the top ten abundant genera. The locations of these 
clouds on the PCoA plot correspond to the abundance of each genera within samples. This 
indicates which genera are driving the clustering of samples. Size of the cloud correlates with the 
abundance of the specific genus within samples. A small number of genera were labeled for 
simplicity. Blautia and Clostridium were the most abundant genera, shown by the size of their 
clouds. Most of the genera are found close together in the large cluster of samples. Meanwhile, 
Pediococcus was the fifth most abundant genera, but was only found near the seven outliers. 
These seven outliers are in center of PC axes. These are the pink, green, light blue, dark blue, 
purple, and grey single samples. Other samples that appear close are due to the captured angle 
(Figure 11 indicates these seven are dissimilar from other samples). These outliers are closest to 
the Pediococcus cloud, indicating this genus primarily affects their clustering.  
      
        
        
        
        
        
        
        
        
        




Figure 13. Genus-level 
taxonomic summaries 
limited to Pediococcus. 
Similar to Figure 5 except 
all non-Pediococcus genera 
are grouped as “Other” 
(green). This highlights the 
high abundance of 
Pediococcus in the five 
room temperature, non-
RNAlater outliers and how 
it is rarely found in other 
samples. Interestingly, 
individual 1001 had <5% 
Pediococcus abundance in 
five of their six total 
samples, but these were not 
to the same degree as the 
room temperature, non-
RNAlater sample. The five 
outliers each had 25-50% 
Pediococcus abundance. 
The remaining two outliers, 
2302RTN and 2401RTN, 
each had less than .03% 
abundance of Pediococcus. 
Nonetheless, they clustered 





Figure 14. Sample photograph prior to MS injection.  
This photograph depicts all 60 samples used for MS analysis. Tubes 
with color are all samples that were not treated with RNAlater and 
therefore did not undergo an RNAlater removal protocol. The tubes 
without any color are samples that underwent the RNAlater removal 
protocol twice. This image highlights the distinct lack of color 
samples had following two RNAlater removals. However, only 12 of 








Metabolome Preservation  
 The goal of this study was to examine how the effects of storage temperature and 
RNAlater treatment impact fecal sample integrity through taxonomic classification with 
16S rRNA gene sequencing and mass spectrometry-based metabolomics. In the 
metabolomics approach, we were unable to generate data from 12 samples that were 
treated with RNAlater and subsequently underwent a RNAlater removal process. Only 
six total metabolites were detected in database searches with only urobilinogen as a 
confirmed match. RNAlater removal is the likely culprit influencing MS analysis and 
sample preservation due to its components commonly interfering with MS analysis. 
Based on the work done for this project, there are two possible explanations for this lack 
of metabolomic data.  
 The first viable answer is that the components of RNAlater mixing with fecal 
samples prevented MS analysis. Other researchers have identified this as the primary 
cause behind metabolomic problems with RNAlater (Sinha et al. 2016; Wang et al. 
2018)⁠. However, this explanation is unlikely when considering the detection of 
urobilinogen and our use of internal standards. While not every tested sample contained 
urobilinogen, its detection in some samples indicates MS analysis performed properly.  
Additionally, all samples had been spiked with internal standards (sulfachloropyridazine 
and sulfadimethoxine) with known masses. Their detection by the MS instrument further 
demonstrates MS analysis performed normally. With both expected molecules and 
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internal standards detected within samples, this suggests MS detection performed as 
expected. This was likely due to the RNAlater removal having succeeded in removing 
the negative contents of RNAlater, which ties into the other potential reason for our 
results.   
 The second possible, and more likely, cause for our results is the design of the 
modified RNAlater removal protocol. It was intended to isolate RNAlater components 
without compromising other analytes, but the protocol was likely too thorough when 
removing molecules. The components of the removal protocol appear to bias polar 
molecules due to usage of methanol for elution. Methanol, a polar solvent, would release 
more polar molecules from the sorbent during elution, potentially causing a low recovery 
of nonpolar molecules. Moreover, methanol was used previously in the RNAlater 
cleanup protocol as part of the washing step. Using methanol as both a washing solvent 
and an elution solvent likely caused target molecules to wash away rather than bind to the 
cartridge for subsequent elution. However, urobilinogen is a nonpolar molecule and it 
was detected within our samples. Therefore, the RNAlater removal protocol’s inclination 
towards polar compounds does not adequately explain why few metabolites were 
detected, but it cannot be ruled out as a potential factor.  
The SPE protocol changed the physical color of samples, which can represent the 
loss of metabolites. Samples generally retained their original color after elution in the 
first RNAlater removal. For stage one samples, the second SPE treatment caused color 
loss for all eluates. Some stage two samples kept their color following their single 
RNAlater removal (Figure 14). According to the Human Metabolome Database (Wishart 
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et al. 2018), some metabolites, such as stercobilin and urobilinogen, are associated with 
feces coloring. The lack of color after RNAlater removal suggests these molecules, as 
well as other color-causing compounds, were lost in RNAlater removal. This observation 
illustrates the thoroughness of the RNAlater removal protocol, which likely caused 
analyte loss. Urobilinogen was found more commonly in samples that underwent a single 
RNAlater removal. The second RNAlater removal largely eliminated urobilinogen from 
samples, reinforcing the idea that the RNAlater removal was too effective. Additionally, 
PCoA plots showed samples clustered strongly based on the number of RNAlater 
removals performed (Figures 4A and 4B). Samples that went through the protocol once 
were grouped together, but samples that underwent the protocol twice occupied the same 
space as each other. Therefore, undergoing the RNAlater cleanup protocol resulted in 
similar metabolomic profiles due to molecule loss, which increased with additional 
RNAlater cleanup. Lastly, the fact our MS analysis performed normally demonstrates 
that our RNAlater removal process was too effective. Since RNAlater ordinarily prevents 
MS analysis from occurring (Loftfield et al. 2016; Sinha et al. 2016)⁠, we would have 
expected our MS analysis to completely fail when using RNAlater samples. Even 
through our protocol did not effectively preserve metabolomic profiles, it appeared to 
remove enough RNAlater products for proper MS analysis. All in all, there is strong 
evidence advocating the design of our RNAlater removal process caused near-total 
analyte loss within our samples, impacting metabolomic profile preservation. With this 




The overall lack of data is consistent with the results of published literature 
(Loftfield et al. 2016; Sinha et al. 2016; Wang et al. 2018). These specific projects 
evaluated different sample storage and treatment methods, including RNAlater, to 
determine their impact on fecal microbiome and metabolomic profiles. All these groups 
were unable to generate untargeted metabolomic data from samples treated with 
RNAlater using a MS instrument. However, none of the other projects attempted to 
remedy the problems RNAlater causes for untargeted metabolomics. To our knowledge, 
this thesis is the first project to explore ways of modifying RNAlater treatment to allow 
for fecal untargeted MS-based metabolomics. While the RNAlater cleanup protocol used 
here was developed from Cottrell et al. 2015, they employed targeted MS analysis on 
mouse bone fracture callus samples, whereas this project focused on untargeted 
screenings of the global fecal metabolomic profile. The work by Cottrell et al. 2015 
signals RNAlater treatment can be tweaked to allow for MS analysis, but the RNAlater 
cleanup protocol used for this thesis was unable to achieve similar success for fecal 
untargeted MS-based metabolomics.  
 While the RNAlater removal protocol did not preserve metabolomic profiles, this 
result shows the limits of storage methods for metabolomics. To improve these limits, 
more research into the effects of RNAlater treatment on sample integrity and whether 
this storage method can be improved is necessary. Future research can start by evaluating 
the modified RNAlater removal protocol provided in this thesis. While we could not 
definitively pinpoint the exact cause or causes of why our RNAlater removal protocol 
failed, future work can address these questions. This project focused on analyzing 
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RNAlater-treated samples but employing MS analysis on non-RNAlater samples is 
crucial for understanding how RNAlater impacts sample preservation. Future work for 
this project should include MS analyses for samples treated with and without RNAlater. 
These non-RNAlater controls are crucial for future work on this thesis. Next, selected 
non-RNAlater samples should also undergo the removal protocol. This would 
demonstrate how the protocol impacts samples and we could compare how RNAlater and 
non-RNAlater samples differ after undergoing the treatment. By understanding how the 
RNAlater removal protocol affects samples on a molecular level, the protocol can be 
improved. Modifications to the protocol could improve untargeted metabolite yield from 
samples treated with RNAlater, possibly enabling RNAlater usage with metabolomic 
samples. Utilizing RNAlater with metabolomic samples would allow researchers to 
perform more types of molecular analyses on a single sample, providing deeper insights 
for molecular anthropology, including microbiome studies.  
 
Microbiome Profile Preservation 
 In this thesis, 16S rRNA gene sequencing was performed to investigate the effects 
of RNAlater and different storage temperatures on the bacterial taxonomic inventories of 
fecal samples. Our most abundant phyla were Firmicutes, Actinobacteria, Bacteroidetes, 
Proteobacteria, and Euryarcheota, and our most abundant genera included Blautia, 
Clostridium, Collinsella, Subdoligranulum, and Pediococcus (Figures 5 and 6). These 
phyla and genera are expected within microbiome profiles of fecal samples (Choo et al. 
2015), indicating our results are consistent with published research. While immediate 
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freezing without storage solutions is accepted as the gold standard for sample 
preservation (Choo et al. 2015; Loftfield et al. 2016), our results suggest that the host was 
the primary factor influencing beta diversity of samples  (Figures 9 and 10), with these 
PCoA plots demonstrating strong clustering when color-coded by host. Samples did not 
cluster according to RNAlater use or storage temperature (Figures 9 and 10), but 
RNAlater treatment and storage temperature caused samples to be different from each 
other (these effects were simply outweighed by the host) when examining beta diversity 
in PCoA plots. Each host had six total samples, but these samples were not identical to 
each other in the PCoA plots (Figures 9 and 10). Furthermore, samples generally 
clustered closer to other samples from the same host rather than a different host. 
Therefore, host differences greatly influenced inter-sample differences in 
presence/absence of taxa as well as the overall abundance of taxa.  
Alpha diversity analyses also indicated that microbial diversity of samples was 
largely influenced by the host who contributed the sample. Kruskal-Wallis and Dunn’s 
test determined the host had a significant influence on both microbial richness and 
phylogenetic diversity of samples when considered alone (Supplementary tables 6A and 
6B, respectively). ANCOVA tests incorporating both RNAlater use and storage 
temperature as covariates reveal that differences in microbial content and abundance 
between samples were primarily determined by the host (Supplementary Table 6C). 
RNAlater use and storage temperature still provided some influence but with less 
pronounced effects (Supplementary table 6C). PERMANOVA tests further confirmed the 
host differences to be statistically significant (Supplementary table 6D). Moreover, this 
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conclusion matches findings from other research where sample treatment influences were 
overshadowed by the host (Choo et al. 2015; Fouhy et al. 2015; Ribeiro et al. 2018; Sinha 
et al. 2016; Wang et al. 2018). Ultimately, it seems that the host was the primary force 
affecting the presence/absence and abundance of bacterial taxa. This holds true when 
evaluated by itself and when RNAlater and storage temperature were considered.  
Alpha diversity analyses reported usage of RNAlater by itself had statistically 
significant effects on both microbial richness and phylogenetic diversity of samples, with 
Kruskal-Wallis and Dunn’s tests determining statistical significance (Supplementary 
tables 6A and 6B, respectively). Furthermore, ANCOVA tests validate that RNAlater had 
significant effects on microbial richness and phylogenetic diversity, even when using 
storage temperature as a covariate (Supplementary table 6C). For eight of the ten host 
sample donors, RNAlater-treated subsamples had higher levels of microbial richness and 
phylogenetic diversity compared to their non-RNAlater counterparts (Figures 7A, 7B, 
and 8A). This conclusion differs from results of another project, where RNAlater was 
noted to have less microbial diversity than frozen samples (Dominianni et al. 2014). Our 
differing results might be caused by the seven Pediococcus outliers skewing the data or 
this thesis’s samples having their microbiome profiles altered after being frozen prior to 
16S analysis (Bahl et al. 2012). Future work is needed to examine how freeze-thaw 
cycles impact microbiome profiles, but our data suggests RNAlater affected the 
microbiome profile of samples, even when considered with storage temperature, although 
this effect was less pronounced than that of the host.  
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 Additionally, alpha diversity analyses demonstrated that storage temperature did 
not have statistically significant effects on microbial richness or phylogenetic diversity 
when considered as a sole factor. Conversely, Figure 8C indicates that room temperature 
samples had less microbial richness and phylogenetic diversity compared to the 4°C and -
80°C samples. However, only the non-RNAlater samples kept at room temperature 
exhibited this decrease (Figure 8C). A Kruskal-Wallis test and Dunn’s test both reported 
the storage temperature differences were not statistically significant (Supplementary 
tables 6A and 6B, respectively), but both tests only examined storage temperature by 
itself. Figure 8B supports this statistical finding, as all storage temperatures displayed 
similar levels of microbial richness when RNAlater was ignored. It seems that 4°C and -
80°C can be effective storage temperatures without RNAlater, but samples will exhibit 
decreased microbial richness and phylogenetic diversity (Figure 8C). Thus, samples 
stored at 4°C and -80°C will be better preserved when treated with RNAlater. Samples 
kept at room temperature without RNAlater show even greater decrease in microbial 
richness and phylogenetic diversity (Figure 8C). This loss could be due to certain 
bacterial taxa blooming when stored at room temperature, known as microbial blooming, 
but it is still unclear (Amir et al. 2017). Despite this, our findings demonstrate storage at 
4°C or -80°C have similar preservation effects, but RNAlater will better preserve 
microbial richness and phylogenetic diversity at 4°C and -80°C and is critical when 
storing samples at room temperature.  
One noteworthy feature of the weighted PCoA plots (Figures 10, 11, and 12) 
show seven outliers separating from the main group of samples clustering by host. These 
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figures had samples clustering by host, but samples usually grouped together in the same 
region of the plot rather than more varied distribution. In the unweighted PCoA plots, 
there was no single large group of sample clustering (Figure 9). Samples organized by 
host, but these host groups were more indiscriminately spread across the plot. These 
seven outliers from the weighted PCoA plots were all from different hosts, were not 
treated with RNAlater, and were stored at room temperature. Examining the taxonomic 
inventories of these samples reveals that five had high levels of the genus Pediococcus, 
making it the fifth most abundant genus across all samples (Figures 6 and 13). The 
remaining two outliers both had less than 0.025% relative abundance of Pediococcus 
(Table 2).  
Pediococcus is a genus of Gram-positive member of the Lactobacillaceae family, 
commonly associated with sauerkraut fermentation (Courage 2019; Woese 1987). As a 
lactic-acid bacterium, Pediococcus is frequently found in the human gut microbiome and 
plays varying roles, such as gluten metabolism (Caminero et al. 2014), probiotics in 
animal-based diets (David et al. 2013), and reductions of the genus have been linked to 
cirrhosis (Schnabl and Brenner 2014). However, its prominence in our data is unusual as 
is not normally a highly abundant genus and is not a focus of fecal microbiome studies. 
Weighted PCoA biplots using the abundance of taxonomic genera further indicate 
that Pediococcus drove the clustering of these outliers (Figure 12). While not all seven 
outliers contained high levels of Pediococcus, its remarkable abundance in these room-
temperature, non-RNAlater samples is noteworthy (Figure 13 and Table 2). Moreover, 
the fact that Pediococcus was not detected in the RNAlater-treated, room temperature 
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samples from these same hosts hints at a relationship between Pediococcus and 
RNAlater. Since Pediococcus was only found in non-RNAlater samples, something in 
RNAlater inhibited Pediococcus growth. To our knowledge, this thesis project is the first 
to notice the potential connections between Pediococcus, high abundance in samples kept 
at room temperature, and RNAlater. 
Microbial blooming is one possible explanation for the high abundance of 
Pediococcus (Amir et al. 2017). In the Amir et al. 2017 study, Lactobacillaceae were 
identified as candidate bloomers at room temperature. However, Pediococcus was not 
described in the article. Two-week storage at room temperature for this thesis possibly 
caused Pediococcus to bloom for non-RNAlater samples, but RNAlater prevented 
Pediococcus blooming. Species-level identification of bacterial taxa corresponding to 
Pediococcus could possibly explain why this genus was found in such high abundance 
under these conditions. Regardless, our treatment methods clearly affected these seven 
sample differently than the rest, with the abundance of Pediococcus being a likely cause. 
Future research can further explore these relationships with the Pediococcus genus.  
 Previous research has indicated that some bacteria, particularly Gram-positive 
bacteria like Firmicutes (such as Pediococcus) and Actinobacteria, will be more abundant 
in frozen samples than fresh samples (Bahl et al. 2012). This change is caused by 
alterations to the cellular structure of Gram-positive bacteria. With the samples used in 
this thesis having undergone multiple freeze-thaw cycles earlier, it is possible this process 
altered the microbiome profiles of these samples before work for this thesis began, such 
as causing Gram-positive bacteria to be found in higher abundance than in fresh samples. 
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This could explain how storage temperature had such minimal negative effects on 
microbiome profiles. If samples were already impacted by multiple freeze-thaws, their 
response to treatment methods would be different to samples that were only frozen once. 
This could also clarify our results contrast with published research. Future work can 
utilize fresh samples as well as samples that underwent varying levels of freeze-thaws to 
track how microbiome profiles change due to storage and treatment methods. Tracking 
the effects of freeze-thaws in this way can shed further light on how current methods, 
including the gold standard of immediate freezing, might be improved. Moreover, 
researchers can examine how certain bacterial taxa are better preserved in samples that 
are fresh, frozen, or treated with storage solutions such as RNAlater. By understanding 
exactly how these preservation methods impact sample integrities, researchers can better 
understand the biological meaning of their results, examine how samples are affected on 
a molecular level, and ensure high-quality data. 
 In conclusion, this thesis demonstrates the crucial nature of evaluating how results 
are affected by sample treatment and molecular preservation. While we were unable to 
preserve the metabolome profiles of our samples, the preservation of microbiome profiles 
in our samples indicates that samples treated with RNAlater will be better preserved than 
samples without RNAlater, regardless of sample storage. For samples not treated with 
RNAlater, 94°C and -80°C will have similar effects on preservation, but room 
temperature storage requires RNAlater to avoid compromising the microbiome profile. 
Our results suggest researchers sampling at field sites can utilize RNAlater as an 
alternative to immediate freezing without dramatically compromising the microbiome 
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integrities of these samples, but more work is needed as our samples had been frozen and 
thawed previously. Moreover, our results validate the essential role that sample treatment 
plays in multi-omics and molecular anthropology projects. Simply by modifying how 
samples were stored and treated, we were unable to generate data for metabolomics, an 
entire field of research. Our efforts to counter this issue failed, but they highlight a core 
problem of sample preservation: choosing how one treats and preserves their samples can 
cut off access to lines of inquiry. Furthermore, whatever method is chosen will still affect 
sample integrity. Ideally, a single sample should allow for multiple lines of analysis, but 
sample storage and treatment processes affect different types of molecules in different 
ways. Current sample preservation methods require researchers to balance the pros and 
cons of these methods in order to generate the data they are interested in. By identifying 
how these methods affect samples molecularly and how these methods can be improved, 
different molecular analysis can be done on a single sample. This idea of molecular 
taphonomy, referring to the study of how molecules are preserved in samples, must be 
explored in greater detail in order to get as much biological information from a sample as 
possible. By expanding our knowledge of molecular taphonomy, sample preservation 
methods, and their recurring issues, these improvements can advance sample collection 
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Appendix I: Supplementary Tables 







0702RTN 1.93 3.26 
0901RTN 3.19 11.6 
1001RTN 1.93 6.63 
1002RTN 2.94 12.8 
1102RTN 7.39 13.6 
1301RTN 1.71 2.99 
2001RTN 9.67 42.3 
2302RTN 12.2 24.2 
2401RTN 5.18 19.9 
3002RTN 5.26 7.81 
0702RTR 3.3 14.5 
0901RTR 4.09 11.4 
1001RTR 4.14 8.42 
1002RTR 5.88 14 
1102RTR 13.8 13.8 
1301RTR 5.25 3.35 
2001RTR 10.9 19.9 
2302RTR 5.31 6.61 
2401RTR 6.2 5.79 
3002RTR 18.1 TOO_LOW 
07024N 1.38 TOO_LOW 
09014N 5.19 14 
10014N 2.25 7.89 
10024N 2.3 6.47 
11024N 11.6 14.6 
13014N 1.67 6.38 
20014N 9.78 41.9 
23024N 10.8 21.8 
24014N 5.33 18.9 
30024N 8.23 16.1 
07024R 3.2 7.21 
09014R 5.58 21.9 
10014R 7.49 23.2 
10024R 4.58 11.4 
11024R 13.1 15.4 
13014R 3.41 6.5 
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20014R 12.3 47.3 
23024R 20.9 2.93 
24014R 12 25.9 
30024R 18.5 27 
070280N 2.57 5.49 
090180N 8.75 32.1 
100180N 6.83 22.8 
100280N 4.67 17.2 
110280N 14.4 21.2 
130180N 2.54 16.2 
200180N 12.6 63 
230280N 13.9 36.6 
240180N 4.27 26.8 
300280N 6.9 16.3 
070280R 2.97 11.5 
090180R 8.73 36.4 
100180R 5.55 27.2 
100280R 4.62 10.6 
110280R 13.5 18.2 
130180R 4.31 14.3 
200180R 16.4 TOO_HIGH 
230280R 9.3 28.2 
240180R 7.43 30.3 
300280R 8.96 30.3 
Table S1. Qubit Values. 
This table lists values from the Qubit Quantification of all 60 samples. Quantification was done 
immediately after DNA extraction. Qubit kits had limited detection ranges, so any values that were outside 
those ranges were designated “TOO_LOW” or “TOO_HIGH”. Samples kept at -80°C tended to have 
higher concentrations. Moreover, samples treated with RNAlater generally had higher concentration values 




qPCR Reaction Sheet 
 35 cycles    
  initial Denature Anneal Elongation 
Temp 95 C 95 C 52 C 72 C 
Time 600 sec 10 sec 20 sec 30 sec 
     







10 770  
V4 F (non-
barcoded) 
0.6 46.2  
V4 R (non-
barcoded) 
0.6 46.2  
         
Total 17   1309  
     
Reaction 17 ul MM    
 3 ul sample    
 20 ul total    
     





Table S2. Reaction Sheet used for qPCR reactions. 
Reaction sheet contains reagents used for master mix, how much of each reagent was used, cycling and 
amplification parameters, and total number of cycles. Number of reactions (rxns) refers to number of 















Position Golay Barcode Reverse Complement Primer# 








































      








































      










































      

























11_02_4_R   4 F6 ATTGAGTGAGTC GACTCACTCAAT 
806rcbc35
3 










      



























24_01_-80_N 4 F7 TTATGGTACGGA TCCGTACCATAA 
806rcbc35
4 










      

























13_01_-80_R 4 F8 GCTAGTTATGGA TCCATAACTAGC 
806rcbc35
5 










      

























































Position Golay Barcode Reverse Complement Primer# 
10_01_RT_

























































      



















































Table S3. Sample to Barcode Pairings. 
These tables contain the samples used and their corresponding reverse barcodes. PCR replicates were done 
using these unique sample-to-barcode matches. The E. coli standards appear twice because the B1 barcode 
ran low for the last replicates. B2 was used as a result. Following qPCR data analysis, samples were split 
into two groups based on their CQ values. Groups were amplified by a different number of cycles. 
(A) PCR Group 1. All were amplified to 18 cycles.   




PCR Reaction Sheets 
A         B 
Amplify for 18 cycles
initial Denature Anneal Elongation Final
Temp 98 C 98 C 52 C 72 C 72 C
Time 30 s 15 sec 20 sec 30 sec 300 sec





Illumina V4 F 
primer 10uM
1 61
10mM dNTPs 0.4 24.4
Phusion HS II 
enzyme
0.2 12.2
BSA 2.5 mg/ml 0.8 48.8
Total 13 793
Reaction  13 ul MM
3 ul sample




Amplify for 20 cycles
initial Denature Anneal Elongation Final
Temp 98 C 98 C 52 C 72 C 72 C
Time 30 s 15 sec 20 sec 30 sec 300 sec





Illumina V4 F 
primer 10uM
1 20
10mM dNTPs 0.4 8
Phusion HS II 
enzyme
0.2 4
BSA 2.5 mg/ml 0.8 16
Total 13 260
Reaction  13 ul MM
3 ul sample





         
Table S4. Reaction Sheets used for PCR. 
These sheets detail the reagents compromising the master mix, how much of each reagent was used, PCR 
conditions, and number of amplification cycles. Number of rxns still refers to number of samples plus 10%.   
(A) PCR Group 1.  




MZMine Data Processing Parameters 
 
Table S5. Parameters for MZMine Data Analysis. 
Column 1 refers to the different steps of data processing in MZMine. Each step had different parameters 
and values, as shown here. Columns 2 and 3 correspond to the parameter and the input value, respectively. 
Retention time is referred to as RT. 
MS1 Noise Level 8.00E+04
MS2 Noise Level 5.00E+03
Mass Detector Centroid
Minimum Time Span (min) 0.05
Minimum Height 2.40E+05
m/z tolerance (ppm) 10
Min peak height 2.40E+05
Peak duration range (min) 0-2.00
Baseline level 8.00E+04
m/z Range (Da) 0.01
RT range (min) 0.1
RT tolerance (min) 0.1
m/z tolerance (ppm) 10
Monotonic shape Yes
Max charge 3
Representative isotope Lowest m/z
m/z tolerance (ppm) 10
m/z to RT weight 5 to 1
RT tolerance (min) 0.1
Require same charge state Yes
RT range (min) 0.2-12
Keep only peaks with MS2 scan Yes
Minimum peaks per row 2
Minimum peaks per isotope 2
Intensity tolerance (%) 10
m/z tolerance (ppm) 10



























































































































































































































































RNAlater Use & 
ANCOVA 
RNAlater F-
value = 6.295 
















































































Table S6. Values from various statistical tests. These tables are separated by the test performed. First 
column refers to the type of analysis the test acted on. Second column is the category/variable considered in 
these tests. Each statistical test has different considerations so these varied, but primarily focused on the 
effects of Individual (host), RNAlater use, and Storage Temperature. Third column is the name of the test. 
The fourth column contains the test statistic values from these tests. These statistics will be different 
between tests. The fifth column contains the p-value from each test. The sixth and last column says whether 
the results were statistically significant. For this project, statistical significance was defined as p-value 
<0.05.  
(A) Results from the Kruskal-Wallis test by ranks, also known as a one-way ANOVA. This nonparametric 
test evaluates whether significant differences exist in independent samples. This test was run on results 
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from alpha diversity and found that host and RNAlater use caused significant differences for both 
phylogenetic diversity and microbial richness. Storage temperature did not have significant effects.   
(B) Results from Dunn’s test of multiple comparisons. Typically done on a significant result from Kruskal-
Wallis to correct for errors in the Kruskal-Wallis test. These results validated the findings of our Kruskal-
Wallis tests: host and RNAlater use had significant effects and storage temperature did not. 
(C) Results from ANCOVA tests, also known as analysis of covariance. ANCOVA evaluates whether an 
independent variable has significant effects on a dependent variable while considering the effects of a 
different independent variable (called the covariate). The test provides results for all variables, so the values 
for each specific variable are listed. These ANCOVA results indicate if each independent variable had 
significant effects on the dependent variable, and if these independent variables affected each other. Our 
results indicate individual and RNAlater caused significant effects, validating the results from Kruskal-
Wallis and Dunn’s tests. However, these variables did not have significant effects on each other. Storage 
temperature did not have significant effects on samples or on other variables. Our conclusions from 
ANCOVA match those from earlier tests, but further confirm that host and RNAlater caused significant 
effects and did not affect each other. 
(D) PERMANOVA results. Known as Permutational Analysis of Variance, this non-parametric test 
evaluates significant differences between groups while considering multiple variables. PERMANOVA also 
considers permutations to ensure accurate results. Our PERMANOVA results indicate that host, RNAlater 
use, and storage temperature all had significant effects between samples. The significance of storage 
temperature contrasts with results from alpha diversity and with PCoA plots, but storage temperature still 
caused differences between samples. These temperature effects were largely outweighed by the influence 
of the host. We can conclude that storage temperature and RNAlater use will still affect the microbiome 









Number of Samples 
with >0% Abundance 
Number of Samples 
with >2% Abundance 
Firmicutes 0.766368056 60 60 
Actinobacteria 0.146322222 60 60 
Bacteroidetes 0.032993056 60 24 
Proteobacteria 0.0249375 60 14 
Euryarchaeota 0.012948611 38 14 
Tenericutes 0.009440278 60 10 
Cyanobacteria 0.004248611 58 0 
Verrucomicrobia 0.002077778 15 4 
Spirochaetes 0.000518056 22 0 
Streptophyta 8.19444E-05 14 0 
Elusimicrobia 3.61111E-05 7 0 
Fusobacteria 1.66667E-05 7 0 
Lentisphaerae 5.55556E-06 2 0 
Synergistetes 2.77778E-06 2 0 
Chloroflexi 1.38889E-06 1 0 














Blautia 0.10365 60 54 
Clostridium 0.083161111 60 47 
Collinsella 0.063786111 60 47 
Subdoligranulum 0.0414125 60 40 
Pediococcus 0.035995833 47 10 
Romboutsia 0.035770833 60 37 
Holdemanella 0.032661111 57 27 
Catenibacterium 0.031088889 52 19 
Prevotella 0.030095833 59 21 
Bifidobacterium 0.028334722 45 12 





(Unknown genus) 0.025148611 60 31 
Lactobacillus 0.024423611 60 17 
Ruminococcaceae 
Ruminococcus_g2 
(Unknown genus) 0.023888889 60 22 
Enterococcus 0.020926389 57 13 
Turicibacter 0.01985 60 17 
Terrisporobacter 0.0192125 60 17 
Mogibacterium 0.014624294 49 11 
Escherichia 0.015484722 60 9 
Olsenella 0.015338889 54 16 
Ruminococcaceae 
JN713389_g 
(Unknown genus) 0.015231944 60 11 
Intestinibacter 0.015101389 60 17 
Faecalibacterium 0.014279167 60 16 
Dorea 0.014272222 60 18 
Agathobacter 0.012163889 58 9 
Bulleidia 0.011606944 56 11 
Weissella 0.011316667 52 4 
Coriobacteriaceae 
JN162689_g 
(Unknown genus) 0.011129167 52 7 
Sporobacter 0.010763889 60 5 
Lachnospiraceae 
Ruminococcus_g4 
(Unknown genus) 0.010102778 59 11 
Table S7. Most Abundant Phyla and Genera. 
These data come from the rarefied output files, resulting in 12,000 reads per sample. There were 60 total 
samples at this point. Positive controls were excluded here. Table is sorted in order of descending 
abundance. Each row corresponds with a different phyla or genera, as indicated by column one. The second 
column refers to the average frequency of the specific phyla/genera across all samples. This indicates the 
percentage of the 12,000 reads per sample that matched to the specific phylum/genus. Columns three and 
four represent the total number of samples containing the specific phylum/genus with at least 0% and 2% 
relative abundance, respectively. 
(A) These are the detected phyla across all samples. A total of 16 phyla were identified. Firmicutes 
dominates the phyla here, as expected in fecal microbiome profiles. Actinobacteria, Bacteroidetes, 
Proteobacteria, and Euryarcheota follow Firmicutes, but with significantly less abundance. Eight of these 
16 phyla do not contain more than 2% abundance in a single sample, suggesting the distribution of phyla 
was primarily limited to a handful of phyla.  
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(B) The top 30 abundant genera across all samples. A total of 336 genera were identified, but 30 are 
presented here. Blautia was the most abundant genus, as expected in fecal microbiome profiles. 
Clostridium, Collinsella, Subdoligranulum, and Pediococcus were the next most abundant genera. Column 
four indicates that the number of samples with at least 2% abundance of the specific genus varied more so 




SampleID Individual RNAlater StorageTemp Cleanups# Urobilinogen 
10_02_RT_1removal 10_02 Y RT (22-
25°C) 
1 Yes 
13_01_4_1removal 13_01 Y 4°C 1 Yes 
13_01_80_1removal 13_01 Y -80°C 1 No 
10_02_80_1removal 10_02 Y -80°C 1 No 
11_02_80_2removal 11_02 Y -80°C 2 No 
10_01_80_2removal 10_01 Y -80°C 2 Yes 
23_02_4_1removal 23_02 Y 4°C 1 Yes 
07_02_80_2removal 07_02 Y -80°C 2 No 
20_01_80_2removal 20_01 Y -80°C 2 Yes 
20_01_RT_1removal 20_01 Y RT (22-
25°C) 
1 Yes 
23_02_80_1removal 23_02 Y -80°C 1 Yes 
blank_1 blank N NA 0 No 
Table S8. Sample information for metabolomic analysis. 
These are the twelve samples that were analyzed on the MS with their corresponding metadata information. 
First two numbers refer to family and individual (##_##). After the name, storage temperature is RT (room 
temperature), 4 (4°C), and 80 (-80°C). The final part of the name refers to the number of RNAlater cleanup 
protocols the samples went through: 1removal (1 cleanup) and 2removal (2 cleanups). Metabolomic 
analyses were limited to the individual/host, RNAlater use, storage temperature, and number of RNAlater 











07024N 702 4 N 68,196.00 30.91952 479.0285714 317 
07024R 702 4 Y 86,829.00 30.58945 390.6842105 314 
070280N 702 80 N 86,566.00 29.19883 378.0227273 293 
070280R 702 80 Y 58,686.00 27.51803 373.7368421 282 
0702RTN 702 RT N 71,189.00 24.80942 363.6756757 243 
0702RTR 702 RT Y 59,957.00 28.73366 422.2777778 306 
09014R 901 4 Y 146,735.00 27.86527 339.42 273 
090180N 901 80 N 216,028.00 27.04321 368.5294118 266 
090180R 901 80 Y 212,199.00 27.5375 371.1395349 278 
0901RTN 901 RT N 137,762.00 24.86659 352.9166667 249 
0901RTR 901 RT Y 107,769.00 26.98019 389.375 267 
09014N 901 4 N 148,265.00 27.65255 357.2272727 278 
10014N 1001 4 N 78,073.00 22.21157 329.4545455 210 
10014R 1001 4 Y 86,884.00 24.51685 336.3333333 231 
100180N 1001 80 N 137,098.00 23.40074 281.9655172 208 
100180R 1001 80 Y 76,928.00 26.76917 366.3636364 253 
1001RTN 1001 RT N 12,758.00 21.48344 256.0967742 189 
1001RTR 1001 RT Y 59,866.00 25.52583 303.5172414 234 
10024N 1002 4 N 80,380.00 21.80402 317.037037 225 
10024R 1002 4 Y 71,311.00 24.57321 345.7241379 234 
100280N 1002 80 N 99,103.00 20.80152 300.0384615 215 
100280R 1002 80 Y 78,486.00 23.94963 309.8780488 244 
1002RTN 1002 RT N 177,581.00 17.96618 280.6363636 174 
1002RTR 1002 RT Y 106,493.00 21.71453 295.0294118 224 
11024N 1102 4 N 102,164.00 26.66412 331.8484848 250 
11024R 1102 4 Y 133,329.00 28.02333 404.5333333 274 
110280N 1102 80 N 158,068.00 27.23012 375.25 274 
110280R 1102 80 Y 150,935.00 30.65894 391.0666667 296 
1102RTN 1102 RT N 129,626.00 24.60702 328.8857143 234 
1102RTR 1102 RT Y 101,531.00 28.63765 358.3488372 283 
13014N 1301 4 N 45,231.00 31.599 381.3333333 302 
13014R 1301 4 Y 148,170.00 31.85311 465.097561 308 
130180N 1301 80 N 71,614.00 31.65805 452 296 
130180R 1301 80 Y 57,857.00 32.18994 531 327 
1301RTN 1301 RT N 37,263.00 33.5229 420.1666667 321 
1301RTR 1301 RT Y 54,825.00 33.21517 447 327 
20014N 2001 4 N 150,426.00 26.08141 366 234 
20014R 2001 4 Y 114,140.00 28.1145 439.15625 275 
200180N 2001 80 N 178,278.00 23.34557 278.1538462 218 
200180R 2001 80 Y 274,649.00 28.79424 388.6756757 278 
2001RTN 2001 RT N 140,656.00 23.89523 299.125 217 
2001RTR 2001 RT Y 83,659.00 28.0913 392.1764706 277 
23024N 2302 4 N 182,171.00 33.95504 538.4545455 373 
23024R 2302 4 Y 197,924.00 37.44313 558.5 428 
230280N 2302 80 N 173,645.00 34.60156 597.4285714 390 
230280R 2302 80 Y 112,996.00 36.65942 520.8 413 
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2302RTN 2302 RT N 173,188.00 29.73521 410 311 
2302RTR 2302 RT Y 97,993.00 36.2905 516.2 407 
24014N 2401 4 N 114,796.00 25.08086 365.1538462 267 
24014R 2401 4 Y 135,648.00 30.33615 450.4642857 291 
240180N 2401 80 N 80,990.00 27.3397 438.0285714 285 
240180R 2401 80 Y 145,291.00 29.22783 429.0277778 305 
2401RTN 2401 RT N 168,097.00 23.10736 353.6666667 222 
2401RTR 2401 RT Y 76,867.00 29.06668 450.5 305 
30024N 3002 4 N 159,652.00 25.79397 406.6 279 
30024R 3002 4 Y 177,542.00 28.8064 418.125 318 
300280N 3002 80 N 138,921.00 26.83494 380.2439024 289 
300280R 3002 80 Y 150,606.00 28.27993 398.9354839 297 
3002RTN 3002 RT N 217,085.00 26.18505 331.4285714 250 
3002RTR 3002 RT Y 111,187.00 29.15452 396.1621622 315 
Table S9. Sample information for microbiome analysis and results. 
All 60 samples that underwent 16S rRNA gene sequencing are listed. Blanks and positive controls were not 
included in this chart. Sample naming system continues as family and individual, storage temperature, and 
RNAlater. Column 5 contains the number of 16S reads mapped to each sample. Columns 6,7, and 8 
correspond to phylogenetic diversity, chao1, and number of observed OTUs, respectively. QIIME1 was 































































bp 25.5 1.29 93.64     
 




bp 25.5 1.29 93.13     
 
Table S10. MiSeq Run Summary and Metrics. 
Results table was acquired from Illumina BaseSpace SequenceHub for the MiSeq run performed for this 
thesis. 1 lane of the MiSeq flowcell was used for 3 reads. Reads 1 and 3 ran for 251 cycles each, while read 
2 ran for 12 cycles. This was because a 2x250 paired-end run was performed. 5.98 giga base pairs (Gbp, 
equivalent to 1,000,000 base pairs) were acquired in the run. Of all the total reads, 25.5% aligned to the 
PhiX positive control to ensure the MiSeq run performs as it should. 12,588,365 total reads were detected 
by the MiSeq and 11,704,428 of these reads passed the filtering criteria. This equals 92.99% of the total 
reads passing filter and mapping as 16S reads. 93.13% of the total reads were Q30, meaning there was a 
1:1,000 chance that a base was incorrectly identified.     
 
